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ABSTRACT
Background: Remote preconditioning is a phenomenon in which brief episodes of ischemia and reperfusion to 
remote organs protect the target organ against sustained ischemia/reperfusion (I/R)-induced injury. Protective 
effects of remote aortic preconditioning (RAPC) are well established in the heart, but their mechanisms still 
remain to be elucidated. Objective: This study has been designed to investigate the possible involvement of 
-1-adrenergic receptor (AR) and KATP channels in cardio-protective effect of RAPC in isolated rat heart. 
Materials and Methods: Four episodes of ischemia and reperfusion, each comprising of 5 min occlusion and 
5 min reperfusion, were used to produce RAPC. Isolated perfused rat heart was subjected to global ischemia for 
30 min followed by reperfusion for 120 min. Coronary efﬂ  uent was analyzed for LDH and CK-MB release to 
assess the degree of cardiac injury. Myocardial infarct size was estimated macroscopically using TTC staining. 
Results: Phenylephrine (20 g/kg i.p.), as -1-AR agonist, was noted to produce RAPC-like cardio-protection. 
However, administration of glibenclamide concomitantly or prior to phenylephrine abolished cardioprotection. 
Moreover, prazocin (1 mg/kg. i.p), as -1-AR antagonist and glibenclamide (1 mg/kg i.p), a KATP channel 
blocker, abolished the cardioprotective effect of RAPC. Conclusion: These data provide the evidence that 
-1-AR activation involved in cardioprotective effect of RAPC-mediated trough opening of KATP channels.
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INTRODUCTION
Coronary artery disease represents a global burden on health 
care resources, and it is the leading cause of morbidity and 
mortality in the world by 2020.[1] Repeated short episodes 
of ischemia and reperfusion have been demonstrated to 
make myocardium transiently more resistant to deleterious 
effects of prolonged ischemia and this paradoxical form 
of myocardial adaptation has been termed as ischemic 
preconditioning.[2] The occlusion of circumﬂ  ex artery 
has produced protection of myocardium supplied by left 
anterior descending coronary artery and this phenomenon 
is termed as intracardiac preconditioning.[3] Short occlusion 
of renal[4] abdominal aorta or mesenteric artery[5] has been 
documented to prevent myocardium against ischemia 
and reperfusion-induced injury. This phenomenon has 
been termed as “remote preconditioning” or intraorgan 
preconditioning or preconditioning at distant site.[6,7] RAPC 
is well-documented in various animal models, but the 
molecular mechanism involved in remote preconditioning 
is still not well deﬁ  ned.
Previous studies reported that norepinephrine is 
involved in ischemic preconditioning. Depletion of 
norepinephrine from sympathetic neurons abolishes 
ischemic preconditioning, and tyramine-induced release 
of norepinephrine from sympathetic neurons mimics 
ischemic preconditioning.[8] Ischemic preconditioning is Taliyan, et al.: Possible involvement of α1-adrenergic receptor and KATP channels in cardioprotective effect.
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also mimicked by phenylephrine -1-adrenergic receptor 
(AR) agonist and blocked by prazocin 1-AR antagonist, 
suggesting that ischemic preconditioning is mediated by 
-1-ARs.[9] However, some investigators have reported 
that adrenergic stimulation or 1-AR agonist methoxamine 
did not precondition the dog heart.[10] Moreover, 1-AR 
blockade did not abolish ischemic preconditioning in 
the rat heart.[11,12] Thus, the role of AR in ischemic 
preconditioning has been a source of controversy.
The activation of α-1-ARs has been shown to hydrolyse 
phosphoinositides and produce diacylgleserol (DAG).   
Hydrolysis of phosphoinositides can lead to mobilization 
of calcium and production of diacylglycerol, which together 
are proposed to activate protein kinase C (PKC). The PKC 
is known to activate KATP channels and precondition the 
myocardium.[13,14] 
Therefore, this study has been designed to investigate the 
effect of α-1-AR and KATP channels in cardioprotective 
effect of remote aortic preconditioning (RAPC).
MATERIALS AND METHODS
Wister albino rats of either sex weighing 200–300 were 
employed in this study. The animal experiments were 
conducted in accordance with guidelines of US National 
Institute of Health for care and use of laboratory animals 
and the study protocol was approved by Institutional Ethics 
Committee.
Induction of remote aortic preconditioning
Induction of RAPC was carryout out according to earlier 
reported by Singh and Sharma.[15] In brief, each rat was 
anesthetized with thiopental sodium (40 mg/kg, i.p.). A 
2-cm long incision was given on the abdomen. Lower 
portion of abdominal aorta was isolated below the point 
of origin of renal artery, and a silken suture (numbered 
5/0) was used to make a shoelace knot to occlude the 
abdominal aorta and knot was untied for reperfusion. Four 
episodes of ischemia and reperfusion, each comprising 
of 5 min occlusion and 5 min reperfusion, were used to 
produce RAPC.
Isolated perfused rat heart
In brief, heart was rapidly excised and immediately 
mounted on Langendorff’s apparatus. Isolated heart was 
retrogradely perfused at constant pressure of 80 mmHg 
with Kreb’s Henseleit (KH), maintained at 37 °C, bubbled 
with 95% O2 and 5% CO2. Flow rate was maintained at 7–9 
mL/min using Hoffman’s screw. The heart was enclosed 
in a double wall jacket, the temperature of which was 
maintained by circulating water heated to 37 °C. Global 
ischemia was produced for 30 min by blocking the inﬂ  ow 
of KH solution. It was followed by reperfusion for 120 
min. Coronary efﬂ  uent was collected immediately 30 min 
after reperfusion for estimation of lactate dehydrogenase 
(LDH) and 5 min after reperfusion for estimation of 
creatine kinase (CK-MB).
Assessment of myocardial infarct size
Infarct size was measured by macroscopic method using 
TTC-staining dye, and the infracted area reported as the 
percentage of total ventricular area.[16] In brief, hearts 
were removed from the Langendorff’s apparatus and both 
the auricles and the root of the aorta were excised, and 
the ventricles were frozen. These were then sliced into 
uniform sections of 2–3 mm thickness and incubated in 
1% triphenyltetrazolium chloride (TTC), at 37 °C in 0.2 
M Tris buffer (pH 7.4) for 20 min. TTC was converted to 
red formazone pigment by reduced nicotinamide adenine 
dinucleotide (NADH) and dehydrogenase enzyme and, 
therefore, stained the viable cells deep red, while the 
infracted cells remained unstained or dull yellow. The 
ventricular slices were placed between two glass plates 
and a transparent plastic grid with 100 squares in 1 cm2 
was placed above it. The average area of each slice was 
calculated by counting the number of squares on either 
side and similarly the stained and   unstained or dull yellow 
area was counted. The infracted area was expressed as a 
percentage of the total ventricular area.
Estimation of lactate dehydrogenase 
Lactate dehydrogenase (LDH) was estimated in samples 
of coronary effluent collected after stabilization and 
immediately and 30 min after reperfusion using 2,4-DNPH 
method as described by King.[17]
Estimation of creatine kinase
Creatine kinase (CK-MB) was measured in samples 
of coronary efﬂ  uent after stabilization and 5 min after 
reperfusion using modiﬁ  ed method of Hughes.[18]
Experimental protocol
Ten groups, each group comprised of six Wistar albino 
rats, were employed in this study.
Group I (Sham control; n = 6): Rats were subjected to 
surgical procedures to isolate abdominal aorta and to pass Taliyan, et al.: Possible involvement of α1-adrenergic receptor and KATP channels in cardioprotective effect.
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ligature beneath it, but aorta was not occluded. Hearts were 
excised 40 min after isolation of aorta and isolated hearts 
were perfused continuously on Langendorff’s apparatus 
for 160 min without subjecting them to global ischemia 
and reperfusion. 
Group II (Control group; n = 6): Rats were subjected to 
surgical procedures to isolate abdominal aorta, but aorta 
was not occluded. Hearts were excised 40 min after the 
isolation of aorta and isolated hearts were perfused on 
Langendorff’s apparatus and were subjected to global 
ischemia for 30 min followed by reperfusion for 120 min.
Group III (Remote aortic preconditioning group; n = 
6): Rats were subjected to surgical procedures to isolate 
abdominal aorta. Four episodes, each episode comprising 
5 min occlusion and 5 min reperfusion were carried out 
of RAPC. Hearts were excised immediately after the last 
episode of preconditioning, perfuse on Langendorff’s 
apparatus and were subjected to global ischemia for 30 
min followed by reperfusion for 120 min.
Group IV (Prazocin treated control group; n = 6): Rats 
were administered prazocin (1 mg/kg, i.p.), a selective α1-
antagonist, 1 h before isolation of abdominal aorta. Rest 
of protocol was the same as described in group II.
Group V (Glibenclamide-treated control group, n = 6): 
Rats were administered glibenclamide (1 mg/kg, i.p.) KATP 
channel blocker, 2 h before isolation of abdominal aorta. 
Rest of protocol was the same as described in group II.
Group VI (Phenylephrine-treated control group): Rats 
were administered phenyephrine (1 mg/kg and 20 μg/
kg, i.p.), a selective α-1 agonist, 1 h before isolation 
of abdominal aorta. Rest of protocol was the same as 
described in group II.
Group VII (Phenylephrine- and glibenclamide-treated 
group; n = 6): Rats were administered glibenclamide and 
phenyephrine (1 mg/kg and 20 μg/kg, i.p.), a selective α-1 
agonist, 2 h and 30 min before isolation of abdominal aorta, 
respectively. Rest of protocol was the same as described 
in group II.
Group VIII (Prazocin-treated remote aortic preconditioning 
group; n = 6): Prazocin (1 mg/kg, i.p.) was administered 
to rats 1 h before isolation of abdominal aorta. Rest of 
protocol was the same as described in group III.
Group IX (Glibenclamide-treated remote aortic 
preconditioning group; n = 6): Rats were administered 
glibenclamide (1 mg/kg, i.p.) 2 h, before isolation of 
abdominal aorta. Rest of protocol was same as described 
in group III.
Group X (Glibenclamide- and prazocin-treated remote 
aortic preconditioning group; n = 6): Rats were administered 
glibenclamide (1 mg/kg, i.p.) and prazocin (1 mg/kg, i.p.) 2 
h and 1 h, respectively, before isolation of abdominal aorta. 
Rest of protocol was the same as described in group III.
Statistical analysis
Values were expressed as mean ± SD for six animals. One-
way ANOVA followed by Dunnett’s test were employed as 
post hoc tests for multiple comparisons. Value of P < 0.05 
was considered to be statistically signiﬁ  cant.
Drugs and chemicals
Prazocin (10 mg/mL) was purchased from Smart Pharm 
Pvt Ltd., India. Glibenclamide (Ind-Swift Ltd., Parmanu, 
India) were dissolved in PEG 400 (Ranbaxy Fine Chemicals 
Ltd.) before use. Tris buffer was prepared by adding 50 
mL of 0.2 M Tris (CDH Chemicals, Delhi, India) in 32.5 
mL of 0.2 HCl and volume was made up to 200mL with 
distilled water. All other reagents used in the study were 
of analar grade (Glaxo, Mumbai, India).
RESULTS
Effect of remote aortic preconditioning on ischemia 
and reperfusion-induced myocardial injury
Global ischemia for 30 min followed by reperfusion for 120 
min signiﬁ  cantly increased myocardial infarct size, release 
of LDH, and CK-MB in coronary efﬂ  uent (P < 0.05). 
However, effect of remote aortic preconditioning (RAPC) 
signiﬁ  cantly attenuated ischemia and reperfusion-induced 
increase in myocardial infarct size (P < 0.01), [Figure 1], 
release of LDH (P < 0.05) [Figure 2], and CK-MB (P < 
0.05) [Figure 3], respectively.
Effect of pharmacological interventions on 
cardioprotective effect of remote aortic preconditioning
The administration of prazocin (1 mg/kg, i.p.) and 
glibenclamide (1 mg/kg, i.p.) produced no marked 
effect on ischemia and reperfusion-induced increase in 
myocardial infarct size, release of LDH, and CK-MB in 
coronary efﬂ  uent. However, prazocin and glibenclamide 
significantly prevented RAPC-induced decrease in 
myocardial infarct size (P < 0.01) [Figure 4] release of LDH Taliyan, et al.: Possible involvement of α1-adrenergic receptor and KATP channels in cardioprotective effect.
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Figure 1 : Effect of remote aortic preconditioning (RAPC) on myocardial 
infarct size measured by volume (vol.) and weight (wt.) method. Results: 
Each value is expressed as mean ± SD for six animals. a = P < 0.01 
vs. Sham. b = P < 0.01 vs. control I/R, respectively. I/R = Ischemia and 
reperfusion, RAPC = remote aortic preconditioning.
Figure 2: Effect of remote aortic preconditioning (RAPC) on release 
of lactate dehydrogenase (LDH) in coronary efﬂ  uent. Results: Values 
are expressed as mean ± SD for six animals. a = P < 0.05 vs. Basal. 
b = P < 0.05. RAPC: remote aortic preconditioning.
Figure 3: Effect of remote aortic preconditioning on release of creatine 
kinase (CK-MB) in coronary efﬂ  uent. Results: Values are expressed 
as mean ± SD for six animals. a = P < 0.01 vs. Basal. b = P < 0.05 
vs. I/R injury.
Figure 4: Effect of remote aortic preconditioning (RAPC) and 
pharmacological interventions on myocardial infarct size. Results: 
Each value is expressed as mean ± SD for six animals. For volume 
method: a = P < 0.05 vs. Sham. b = P < 0.05 vs. control. c = P < 0.05 
vs. RAPC, *P < 0.01. For weight methods: a = P < 0.05 vs. Sham. b 
= P < 0.05 vs. control. c = P < 0.05 vs. RAPC, *P < 0.01. RAPC = 
remote aortic preconditioning. PE = phenylephrine; Prz = prazocin; 
Glb = glebenaclamide.
Figure 5: Effect of remote aortic preconditioning (RAPC) and 
pharmacological interventions on release of lactate dehydrogenase 
(LDH) in coronary efﬂ  uent.  Values are expressed as mean ± SD for 
six animals. a = P < 0.05 vs. Sham. b = P < 0.05 vs. control (I/R). c 
= P < 0.05 vs. PE and RAPC. *P < 0.01 vs. RAPC. RAPC = remote 
aortic preconditioning; GLB = glibenclamide; PRZ = prazocin; PE = 
phenylephrine.
Figure 6: Effect of remote aortic preconditioning (RAPC) and 
pharmacological interventions on release of creatine kinase (CK-MB) 
in coronary efﬂ  uent. Each value is expressed as mean ± SD for six 
animals. a = P < 0.05 vs. Sham. b = P < 0.05 vs. control. c = P < 
0.05 vs. PE and RAPC. PE = Phenylephrine; PRZ = prazocin; GLB = 
glibenclamide; RAPC = remote aortic preconditioning.Taliyan, et al.: Possible involvement of α1-adrenergic receptor and KATP channels in cardioprotective effect.
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(P < 0.05) [Figure 5] and CK-MB (P < 0.05) [Figure 6], 
respectively. Moreover, administration of combination 
of prazocin and glibenclamide more markedly prevented 
RAPC-induced decrease in myocardial infarct size (P < 
0.01) [Figure 4], release of LDH (P < 0.01) [Figure 5], 
and CK-MB (P < 0.01) [Figure 6].
On the other hand, administration of phenylephrine 
produced RAPC-like cardioprotective effect as compared 
with control I/R injury rat heart (P < 0.05) which was 
prevented by glibenclamide [Figures 4 and 5]. In addition, 
phenylephrine also enhanced cardioprotective effect of 
RAPC (data not shown). Prazocin and glibenclamide given 
separately and together did not affect coronary ﬂ  ow rate 
and heart rate (data not shown).
DISCUSSION
This study demonstrated the involvement of α-1-AR 
and consequently opening of KATP channels responsible 
for cardioprotection afforded by RAPC. The transient 
occlusion of circumflex artery has been reported to 
produce protection of myocardial region supplied by left 
anterior descending coronary artery.[19,20] Moreover, short 
occlusion and reperfusion of arteries in other anatomical 
region such as abdominal aorta, limb, and renal occlusions 
demonstrated to produce cardio-protection against 
sustained ischemia and reperfusion.[21] Similarly, in this 
study, four episodes of abdominal aortic preconditioning 
have signiﬁ  cantly attenuated ischemia and reperfusion-
induced increase in myocardial infarct size and release of 
LDH and CK-MB. The peak level of LDH and CK-MB 
was observed at 0 and 30 min, and CK-MB at 5 min, 
respectively. This observation is consistent with our 
previous reports.[22] Langendorff’s preparation and working 
heart preparation are hemodynamically comparable 
to investigate the effect of pharmacological agents on 
ischemia and reperfusion-induced myocardial injury.[23] 
Moreover, Langendorff’s preparation permits the use of 
pharmacological interventions without any interference 
due to changes in systemic circulation.[24] Electrical pacing 
has not been used in this study because it is reported 
to release norepinephrine.[25] Therefore, the isolated rat 
heart preparation, perfuse retrogradely on Langendorff’s 
apparatus, has been employed in this study.
Activation of a-1-ARs have been reported to produce 
ischemic preconditioning like cardioprotective effect which 
is attenuated by selective α-1-adrenergic antagonist-like 
prazocin.[26] Ischemic episode of short duration are reported 
to release noradrenaline and produce cardioprotective 
effect through activation of α-1-AR.[27] Activation of α-1-
ARs are noted to activate protein kinase C (PKC) which 
protect heart from ischemia and reperfusion-induced 
injury.[28,29] Horeover, prazocin, an α-1-AR inhibitor, has 
been shown to attenuate the cardioprotective effect of 
ischemic preconditioning.[30] Therefore, it is possible that 
α-1-AR activation involved in cardioprotective effect of 
RAPC. In this study, we observed that prazocin treatment 
attenuated the cardioprotective effect of RAPC, assessed 
in terms of myocardial infarct size (Figure 1, P < 0.05) and 
release of LDH (Figure 2, P < 0.05) and CK-MB (Figure 
3, P < 0.05). Therefore, it may be probable to suggest that 
cardioprotective effect of RAPC may be mediated through 
activation of α-1-ARs.
Previously, Banerjee et al. presented evidence for a role 
of endogenous norepinephrine in preconditioning rat 
hearts. They found that administration of norepinephrine 
or phenylephrine mimicked ischemic preconditioning like 
cardioprotective effect, whereas reserpine (noradrenaline 
depletor), phentolamine, and BE-2254 (a selective a-1-
adrenoceptor antagonist) block ischemic preconditioning-
induced cardioprotection. Moreover, recently it has 
been noted that α-1b-AR activation alleviates ischemia/
reperfusion (I/R)-induced injury by limiting mitochondrial 
Ca2+ overload in heart.[31] We found that administration 
of phenylephrine produced marked cardioprotection as 
compared with I/R injury control rat heart measured 
in terms of LDH, CK-MB, and infarct size. However, 
cardioprotective effect afforded by phenylephrine was 
abolished in rats received glibenclamide concomitantly 
or prior to phenylephrine administration. It indicates 
that a-1-AR activation-mediated preconditioning like 
cardioprotection may occur through opening of KATP 
channels. 
Regulation of ion channel through activation of kinases 
such as protein kinase A (PKA) and PKC is an important 
mechanism that regulates a wide variety of cellular 
functions. The phosphorylation by PKA and PKC on 
serine and threonine residue is known to alter channel 
properties by modifying the kinetics and/or number of 
channels present on plasma membrane, including KATP 
channels.[32] Classical KATP consist of inward rectifier 
Kir6.2 subunits and sulfonylurea receptor subunits (SUR1 
or SUR2). The SUR is a member of the ATP-binding 
cassette (ABC) family of proteins and acts as a regulatory 
subunit, conferring ADP sensitivity and the distinctive 
pharmacological characteristics on the KATP channel 
complex.[33] On the other hand, the Kir6.x subunit forms 
the pore of the channel and mediates the deﬁ  ning ATP-
dependent inhibition of KATP channels.[34] In addition to Taliyan, et al.: Possible involvement of α1-adrenergic receptor and KATP channels in cardioprotective effect.
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being regulated by various nucleotides, KATP channels are 
modulated by hormones, noradrenaline, intracellular signals 
such as G proteins (Gs), phosphatidylinositol-4,5 phosphate 
(PIP2) that modulate KATP channel activity.[35] It has been 
shown that the activities of KATP channels are regulated 
also by PKA.[32] Further, in myocardium, the KATP channels 
are also activated by Gs-coupled receptor stimulation or by 
addition of exogenous PKA.[36] Recently, it was observed in 
animals that the delayed protection following ischemic PC 
is abolished in vivo by chelerythrine, a PKC inhibitor.[37] PKC 
is known to modulate KATP channels.[37] KATP channels are 
well reported to be involved in cardioprotection afforded 
by remote ischemic preconditioning.[38,39] It seems that 
activation of PKA or PKC modulate KATP channels that 
are involved in IP and RAPC.
In this study, we found that glibenclamide, a KATP blocker, 
attenuated RAPC-induced cardioprotection (Figures 4 
and 5, P < 0.05). Our results are fully consistent with 
previous report by Michael et al.[14] In addition, we found 
that phenylephrine produced cardioprotective effect 
similar to RAPC, which was abolished by concurrent 
or prior administration of glibenclamide subjected to 
preconditioning. Phenylephrine is reported to activate 
α-1-ARs, and glibenclamide is documented to block KATP 
channels.[29,33] Therefore, it seems that the cardioprotective 
effect of RAPC may be due to activation of α-1-ARs and 
subsequent opening of KATP channels. Moreover, it appears 
that α-1-ARs is working upstream and acts via activation 
of KATP channels, which subsequently preconditioning 
the rat heart.
On the basis of present data, it is concluded that activation 
of α-1-ARs and consequent opening of KATP channels may 
be responsible for the cardioprotective effect of RAPC. 
Further studies are needed to conﬁ  rm the exact mechanism 
involved in RAPC.
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